News Focus
News Focus
icon url

HyGro

01/12/23 12:15 AM

#558734 RE: SkyLimit2022 #558733

How about the financial interest of the NWBO trial publication "corresponding author" -- how much stock does he have?? Quite a bit.

"Corresponding Author: Marnix L. Bosch, PhD, Northwest Biotherapeutics, Inc, 4800 Montgomery Ln, Bethesda, MD 20814 (marnix@nwbio.com).

Author Contributions: Dr Bosch had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis."